Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 1Classical hematology 1

Conditions

Myelodysplastic Syndromes 83Leukemia, Myeloid, Acute 72Precursor Cell Lymphoblastic Leukemia-Lymphoma 68Leukemia 64Leukemia, Lymphocytic, Chronic, B-Cell 54Lymphoma, Non-Hodgkin 51Multiple Myeloma 48Hodgkin Disease 48Leukemia, Myeloid, Chronic-Phase 47Myeloproliferative Disorders 46Lymphoma, Mantle-Cell 46Lymphoma, Large B-Cell, Diffuse 43Lymphoma, Follicular 43Lymphoma 39Burkitt Lymphoma 39Lymphoma, B-Cell, Marginal Zone 38Leukemia, Myeloid, Accelerated Phase 38Leukemia, Myelomonocytic, Chronic 37Lymphoma, Large-Cell, Immunoblastic 36Leukemia, Myelogenous, Chronic, BCR-ABL Positive 36Congenital Abnormalities 34Anemia, Refractory, with Excess of Blasts 33Blast Crisis 31Dendritic Cell Sarcoma, Interdigitating 28Primary Myelofibrosis 27Myelodysplastic-Myeloproliferative Diseases 25Neoplasms, Plasma Cell 24Recurrence 23Graft vs Host Disease 23Anemia, Refractory 22

Interventions

Imatinib Mesylate 9fludarabine 5Whole-Body Irradiation 5Tacrolimus 5Mycophenolic Acid 5Cyclophosphamide 5Busulfan 5ponatinib 4nilotinib 4fludarabine phosphate 4Peripheral Blood Stem Cell Transplantation 4Cytarabine 3Bone Marrow Transplantation 3venetoclax 2thymoglobulin 2asciminib 2Sirolimus 2Patient Reported Outcome Measures 2Methotrexate 2Mesna 2Melphalan 2Dasatinib 2Behavior Therapy 2Azacitidine 24-methyl-N-(3-(4-methylimidazol-1-yl)-5-trifluoromethylphenyl)-3-(4-pyrazin-2-ylpyrimidin-2-ylamino)benzamide 2zileuton 1spartalizumab 1sabatolimab 1nicotinamide-beta-riboside 1methanesulfonic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Myeloid × Cyclosporine × Myeloid × Clear all
NCT01392989 2019-05-07

Post T-plant Infusion of Allogeneic Cytokine Induced Killer (CIK) Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders

Stanford University

Phase 2 Completed
44 enrolled 13 charts
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Leukemia, Myeloid, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neural Tube Defects

Data powered by HemOnc (CC BY 4.0) Colophon âš¡